PATENT CLAIM ANALYSIS

Application Number: 16155846
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["544", "281000"]

Abstract:
The present teachings provide a compound represented by structural formula (I-0), or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

Claim (Index 20):
The compound of any one of  claims 1 - 5 , wherein R 1  is \u2014NHR b1 , R b1  is (C 1 -C 4 )alkyl optionally substituted with one or more groups selected from hydroxy, (C 1 -C 3 )alkoxy, hydroxy(C 1 -C 3 )alkyl, \u2014SO 2 (C 1 -C 3 )alkyl, (C 3 -C 7 )cycloalkyl, or 3-7 membered heterocycloalkyl containing one ring heteroatom, the heteroatom being oxygen, wherein the (C 3 -C 7 )cycloalkyl or the 3-7 membered heterocycloalkyl substituent is optionally substituted with halogen, hydroxyl, or (C 1 -C 3 )alkyl.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 97.0
- Lexical Diversity: 1.10345
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14443072', '15434275', '14351381', '15543826', '14382123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7950748355371142
- 35 USC 102 Novelty (BERT): 0.5903859222753741
- Combined Prediction Score: 0.7746059442109402
- Mean Citation Score: 421.832804
- Max Citation Score: 504.46133
- Similarity Product: 438.9885527752752

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test